These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1008 related articles for article (PubMed ID: 17659000)
1. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. Fai D; Cassano N; Vena GA J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000 [TBL] [Abstract][Full Text] [Related]
2. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735 [TBL] [Abstract][Full Text] [Related]
4. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090 [TBL] [Abstract][Full Text] [Related]
5. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Majid I Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696 [TBL] [Abstract][Full Text] [Related]
6. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004 [TBL] [Abstract][Full Text] [Related]
7. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283 [TBL] [Abstract][Full Text] [Related]
8. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. Nordal EJ; Guleng GE; Rönnevig JR J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589 [TBL] [Abstract][Full Text] [Related]
9. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898 [TBL] [Abstract][Full Text] [Related]
10. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141 [TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545 [TBL] [Abstract][Full Text] [Related]
12. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204 [TBL] [Abstract][Full Text] [Related]
13. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812 [TBL] [Abstract][Full Text] [Related]
14. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843 [TBL] [Abstract][Full Text] [Related]
15. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study. Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo. Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845 [TBL] [Abstract][Full Text] [Related]
17. Vitiligo, NB-UVB and tacrolimus: our experience in Naples. Baldo A; Lodi G; Di Caterino P; Monfrecola G G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573 [TBL] [Abstract][Full Text] [Related]
18. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125 [TBL] [Abstract][Full Text] [Related]
19. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Berti S; Buggiani G; Lotti T Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060 [TBL] [Abstract][Full Text] [Related]
20. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Kullavanijaya P; Lim HW Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]